Do glucagon-like peptide-1 based therapies alter the risk of late-onset inflammatory bowel disease? Heidi Søgaard Christensen, Diana Vincens Andersen,Tine Jess,Kristine Højgaard AllinDigestive and Liver Disease（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
